December 16, 2015 / 12:31 PM / 2 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Valeant, Array Biopharma, Northrop

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index e-mini futures were higher on Wednesday ahead of a widely expected hike in interest rates by the Federal Reserve later in the day. Dow Jones industrial average futures were up 0.48 percent at 17,635, S&P 500 futures were up 0.42 percent at 2,054 and Nasdaq 100 futures were up 0.42 percent at 4,625.5.

** ARRAY BIOPHARMA INC, Tuesday close $3.83, +29.24 pct premarket

The company said its experimental drug helped patients with a form of melanoma live longer without their cancer progressing, in an ongoing late-stage study.

** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Tuesday close $109.59, +2.75 pct premarket

The Canadian drugmaker cut its revenue and profit forecasts for 2015, but said it still expected double-digit percentage sales growth through higher volumes in 2016.

** NORTHROP GRUMMAN CORP, Tuesday close $187.84, +1.68 pct premarket

The company riding high after its selection to build the next U.S. long-range bomber, says it is investing heavily and hiring workers as part of a focused plan to unveil at least one "big, bold and ingenious" new technology each year.

** ASTRAZENECA PLC, Tuesday close $33.26, +0.81 pct premarket

The British drugmaker has agreed to buy Takeda Pharmaceutical's respiratory business, including expanded rights to roflumilast, a treatment for chronic obstructive pulmonary disease (COPD). The company also said it aims to build up its already strong position in China by making and developing more medicines locally, and will invest more than $800 million in the country over the next 10 years.

** FORD MOTOR CO, Tuesday close $13.87, +0.22 pct premarket

The company said on Tuesday it secured a permit from California to begin testing its self-driving car on public roads from next year.

** BRISTOL-MYERS SQUIBB, Tuesday close $70.22

The drugmaker's closely watched new drug Opdivo, one of the first of a new wave of cancer medicines that boost the immune system, has been rejected as too expensive for treating lung cancer by Britain's cost watchdog.

** BOEING CO, Tuesday close $146.53

The U.S. aircraft maker has signed a deal to supply 10 737-800 passengers jets converted into freighters to cargo carrier China Postal Airlines. (Compiled by Rosmi Shaji in Bengaluru; Edited by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below